Viyash Scientific Limited has announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company’s Board of Directors considered and approved these results, along with the Independent Auditor’s Limited Review Report. The financial statements cover key performance indicators for the specified periods, offering insights into the company’s financial health and operational performance.
Viyash Scientific Limited Announces Q2 FY27 Financial Results
Viyash Scientific Limited, formerly known as Sequent Scientific Limited, has officially released its unaudited standalone and consolidated financial results for the quarter and half-year concluded on September 30, 2026. The company’s Board of Directors convened a meeting on November 13, 2026, to review and approve these financial statements.
Key Financial Highlights and Approvals
During the meeting, the Board considered and approved the Unaudited Standalone and Consolidated Financial Results for the period. Alongside the financial results, the Independent Auditor’s Limited Review Report for the quarter and half-year ended September 30, 2026, was also approved. These outcomes provide stakeholders with a comprehensive view of the company’s financial standing.
The Board meeting commenced at 3:30 p.m. and concluded at 5:15 p.m. Following this announcement, the trading window for the company’s securities will remain closed for 48 hours.
Financial Performance Overview
The released financial statements offer detailed insights into the company’s performance:
Unaudited Standalone Financial Results (Quarter & Half Year Ended September 30, 2026)
- Revenue from operations for the quarter ended September 30, 2026, stood at ₹3,906.50 million.
- Profit after tax (PAT) for the standalone entity was ₹233.60 million for the quarter.
- For the half-year ended September 30, 2026, standalone revenue from operations reached ₹7,443.40 million, with a PAT of ₹442.80 million.
Unaudited Consolidated Financial Results (Quarter & Half Year Ended September 30, 2026)
- Consolidated revenue from operations for the quarter ended September 30, 2026, was ₹9,879.40 million.
- Consolidated profit after tax (PAT) for the quarter was ₹846.50 million.
- For the half-year ended September 30, 2026, consolidated revenue from operations amounted to ₹19,343.00 million, with a PAT of ₹1,639.40 million.
These results reflect the financial activities and performance of Viyash Scientific Limited and its subsidiaries during the reported periods.
Source: BSE
